TARGOCID
400MG INJ/INF/POR PSO LQF 5+5X3ML
| SÚKL code | 0202814 |
|---|---|
| Name of the product | TARGOCID |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | TARGOCID |
| Supplement | 400MG INJ/INF/POR PSO LQF 5+5X3ML |
| Strenght | 400MG |
| Pharmaceutical form | Powder and solvent for solution for injection/infusion/oral solution |
| Package | 5+5X3ML |
| Route | Intramuscular/intravenous/oral use |
| Language of the pack | Czech |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | TEICOPLANIN (TEICOPLANINUM) |
| ATC group | J01XA02 |
| ATC group name | TEIKOPLANIN |
Marketing authorisation information
| Registration Number | 15/ 216/93-B/C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | sanofi-aventis, s.r.o., Praha |
| MA Holder country | ČESKÁ REPUBLIKA |
cz